Transferrin C2 allele, haemochromatosis gene mutations, and risk for Alzheimer's disease [3]

Journal of Neurology Neurosurgery and Psychiatry

Volumn 72, Issue 6, 2002, Pages 820-821

  Lleo A ^a   Blesa, R ^a   Angelopoulos, C ^a   Pastor Rubio, P ^a   Villa, M ^a   Oliva, R ^a   Bufill, E ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; TRANSFERRIN; TRANSFERRIN C2; UNCLASSIFIED DRUG;

ALLELE; ALZHEIMER DISEASE; GENE MUTATION; GENETIC RISK; HEMOCHROMATOSIS; HUMAN; IRON METABOLISM; LETTER; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SENILE PLAQUE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; FEMALE; GENE FREQUENCY; HEMOCHROMATOSIS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TRANSFERRIN;

EID: 0036262473     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.72.6.820     Document Type: Letter

References (5)

1. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
2. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study
3. Association of transferrin C2 allele with late onset Alzheimer's disease
4. Increased frequency of the transferrin C2 subtype in Alzheimer's disease
5. Are hereditary hemochromatosis mutations involved in Alzheimer disease?